Contract 75N91025P00088
Vector Biomed Inc. · Department Of Health And Human Services · November 27, 2024
Vector Biomed Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on November 27, 2024 for $804,000 of work in biological product (except diagnostic) manufacturing. Performance is in Gaithersburg, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N91025P00088
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Gaithersburg, MD
- First action
- November 27, 2024
Description
SERVICES FOR THE PRODUCTION AND STABILITY TESTING OF CLINICAL GRADE LENTIVIRAL VECTOR, IN SUPPORT OF THE HHS, NIH, NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), PEDIATRIC ONCOLOGY
Modification timeline
-
November 27, 2024Base awardSERVICES FOR THE PRODUCTION AND STABILITY TESTING OF CLINICAL GRADE LENTIVIRAL VECTOR, IN SUPPORT OF THE HHS, NIH, NATIONAL CANCER INSTITUTE (NCI), CENTER FOR C$803.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91025P00088?
Contract 75N91025P00088 is a federal contract awarded to Vector Biomed Inc. by Department Of Health And Human Services on November 27, 2024 for $804,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N91025P00088?
Vector Biomed Inc. won contract 75N91025P00088 from Department Of Health And Human Services.
How much is contract 75N91025P00088 worth?
Contract 75N91025P00088 has obligated $804,000 to date.